1. Paxil (paroxetina). Bula do produto.
2. SÜDHOF, T. C. The cell biology of synapse formation. The journal of cell biology, v. 220, n. 7, 2021.
3. NICHOLS, D. E.; NICHOLS, C. D. Serotonin receptors. Chemical reviews, v. 108, n. 5, p. 1614–1641, 2008.
4. ALVAREZ, B. D.; MORALES, C. A.; AMODEO, D. A. Impact of specific serotonin receptor modulation on behavioral flexibility. Pharmacology, biochemistry, and behavior, v. 209, n. 173243, p. 173243, 2021.
5. SINGH, I. et al. Structure-based discovery of conformationally selective inhibitors of the serotonin transporter. Cell, v. 186, n. 10, p. 2160- 2175.e17, 2023.
6. ZHANG, Y.-W.; TURK, B. E.; RUDNICK, G. Control of serotonin transporter phosphorylation by conformational state. Proceedings of the National Academy of Sciences of the United States of America, v. 113, n. 20, 2016.
7. KOWALSKA, M. et al. Paroxetine—overview of the molecular mechanisms of action. International journal of molecular sciences, v. 22, n. 4, p. 1662, 2021.
8. MEYER, Jeffrey H.; KAPUR, Shitij; EISFELD, Beata; et al. The effect of paroxetine on 5-HT2Areceptors in depression: An [18F]setoperone PET imaging study. The American journal of psychiatry, v. 158, n. 1, p. 78–85, 2001. Disponível em: <http://dx.doi.org/10.1176/appi.ajp.158.1.78>. Acesso em: 24/03/2024.
9. VAN HARTEN, J. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clinical pharmacokinetics, v. 24, n. 3, p. 203–220, 1993
Exclusividade médica